| 000 | 01489 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511201405.0 | ||
| 264 | 0 | _c19910312 | |
| 008 | 199103s 0 0 ger d | ||
| 022 | _a1011-6974 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKöhler, M | |
| 245 | 0 | 0 |
_a[Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters]. _h[electronic resource] |
| 260 |
_bBeitrage zur Infusionstherapie = Contributions to infusion therapy _c1990 |
||
| 300 |
_a89-95 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aBlood Viscosity _xdrug effects |
| 650 | 0 | 4 |
_aErythrocyte Count _xdrug effects |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Renal _xblood |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombosis _xblood |
| 700 | 1 | _aMörsdorf, S | |
| 700 | 1 | _aJung, F | |
| 700 | 1 | _aBraun, B | |
| 700 | 1 | _aWaldhausen, P | |
| 700 | 1 | _aPindur, G | |
| 700 | 1 | _aWeber, U | |
| 700 | 1 | _aBosslet, R | |
| 700 | 1 | _aBambauer, R | |
| 700 | 1 | _aJutzler, G A | |
| 773 | 0 |
_tBeitrage zur Infusionstherapie = Contributions to infusion therapy _gvol. 26 _gp. 89-95 |
|
| 999 |
_c1710310 _d1710310 |
||